DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

Arnaud Duchon, Yann Herault

Open source

DOI
10.3389/fnbeh.2016.00104
Published
2016-06-03
Container
Frontiers in Behavioral Neuroscience
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fnbeh.2016.00104,
  title = {DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome},
  author = {Arnaud Duchon and Yann Herault},
  year = {2016},
  journal = {Frontiers in Behavioral Neuroscience},
  doi = {10.3389/fnbeh.2016.00104},
  url = {https://doi.org/10.3389/fnbeh.2016.00104}
}

RIS

TY  - JOUR
TI  - DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
AU  - Arnaud Duchon
AU  - Yann Herault
PY  - 2016
JO  - Frontiers in Behavioral Neuroscience
DO  - 10.3389/fnbeh.2016.00104
UR  - https://doi.org/10.3389/fnbeh.2016.00104
ER  - 

APA

Duchon, A., & Herault, Y. (2016). DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome. Frontiers in Behavioral Neuroscience. https://doi.org/10.3389/fnbeh.2016.00104

Source records